Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.66 |
| ▸ | LPL | P06858 | 10/20 | 0.66 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47074 | 0.88 | LPL (0.53) | LIPGLPLP4HBROCK1 | |
| SCHEMBL10074112 | 0.86 | LPL (0.48) | LIPGLPLP4HB | |
| SCHEMBL10074115 | 0.86 | LPL (0.48) | LIPGLPLP4HB | |
| SCHEMBL17871063 | 0.83 | LPL (0.56) | LIPGLPLDGAT1P4HBROCK1 | |
| SCHEMBL17539929 | 0.81 | LIPG (0.86) | LIPGLPLDGAT1P4HBKEAP1 | |
| SCHEMBL19107132 | 0.81 | LIPG (0.86) | LIPGLPLDGAT1P4HBKEAP1 | |
| SCHEMBL15458626 | 0.81 | LIPG (0.86) | LIPGLPLDGAT1P4HBKEAP1 | |
| SCHEMBL15197437 | 0.81 | LIPG (0.73) | LIPGLPLDGAT1P4HBPDGFRB | |
| SCHEMBL13700830 | 0.81 | LIPG (0.73) | LIPGLPLDGAT1P4HBPDGFRB | |
| SCHEMBL30065945 | 0.81 | LIPG (0.73) | LIPGLPLDGAT1P4HBPDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | DOOSAN SOLUS CO., LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | DOOSAN SOLUS CO., LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| WO-2015156580-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-10-15 | — | — | WO | disclosed |
| WO-2015099438-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 주식회사 두산 | 2015-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OR10J3, ORC3, L1CAM | LIPG 949/4885LPL 772/4885DGAT1 404/4885 |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | OR10J3, L1CAM, ICOSLG | LIPG 717/4885LPL 429/4885DGAT1 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.